Atrys Health (STU:A2T) Short Interest


STU:A2T Atrys Health SA STU:A2T
68 GF Score
Price €2.57
GF Value €3.10
! 5 Warning Signs
View Full Analysis

What is Atrys Health Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:A2T vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Atrys Health's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atrys Health Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Short Interest distribution charts can be found below:

* The bar in red indicates where Atrys Health's Short Interest falls into.


STU:A2T
68GF Score
Atrys Health SA STU:A2T
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Atrys Health (STU:A2T) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €2.57 is trading 17.1% below its estimated GF Value™ of €3.10.

Key valuation signals for STU:A2T:

  • Short Interest:
  • GF Value™: €3.10 vs. price of €2.57 (17.1% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the STU:A2T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atrys Health Business Description

Other Exchanges ATRY:SpainA2T:Germany
Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
68GF Score

Get the complete analysis for STU:A2T

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.57
Price
€3.10
GF Value